α-Globin Genotypes Associated with Hb H Disease: A Report from Oman and a Review of the Literature from the Eastern Mediterranean Region

Abstract α-Thalassemia (α-thal) is the most common autosomal recessive hemoglobinopathy. There is a vast diversity and geographical variability in underlying genotypes in Hb H (β4) patients. Herein, we describe the genotypes found in the largest report of Omani Hb H patients. Moreover, we reviewed and summarized the literature published from the Eastern Mediterranean region. A retrospective review of all genetically confirmed Hb H disease patients diagnosed between 2007 and 2017 at Sultan Qaboos University Hospital, Muscat, Oman, was performed. Hematological parameters and clinical presentations were assessed. Both α-globin genes were screened for deletional and nondeletional mutations using a stepwise diagnostic strategy as described before. A total of 52 patients (27 females and 25 males) with a mean age of 20.6 years (range 0.23–80.0) were molecularly confirmed to carry Hb H disease. The patients had a hemoglobin (Hb) level of 9.3 g/dL (range 5.7–13.0) and mean corpuscular volume (MCV) of 58.4 fL (range 48.2–82.1). A total of eight genotype combinations were identified, with α2 polyadenylation signal mutation (polyA1) (AATAAA>AATAAG (αPA1α/αPA1α), often cited as αT-Saudiα/αT-Saudiα, being the most common (53.8%) followed by –α3.7/– –MED I (28.8%). Our cohort also included patients with combinations of αPA1 with other Hb variants: αPA1α/αPA1α with Hb S (HBB: c.20A>T) trait (n = 2), –α3.7/αPA1α (n = 2) and αcodon 19α (HBA2: c.56delG)/αPA1α (n = 1). Nondeletional Hb H disease due to the αPA1 mutation is the most common in Omanis. Molecular diagnosis is necessary for accurate confirmation of the diagnosis of α-thal, determination of underlying genotypes, follow-up and counseling.

[1]  E. Azizi,et al.  Iranian patients with hemoglobin H disease: genotype–phenotype correlation , 2019, Molecular Biology Reports.

[2]  Pei-Chin Lin,et al.  Clinical Features and Genotypes of Patients with Hemoglobin H Disease in Taiwan. , 2018, Laboratory medicine.

[3]  A. Thabet,et al.  Various α-Thalassemia Genotype Combinations of the Saudi-Type Polyadenylation Signal Mutation (αT-Saudiα) in the Population of Bahrain: An Update of Genotype-Phenotype Analyses , 2018, Hemoglobin.

[4]  S. Farashi,et al.  Point mutations which should not be overlooked in Hb H disease , 2016, Expert review of hematology.

[5]  J. Borgio.  Molecular nature of alpha-globin genes in the Saudi population , 2015, Saudi medical journal.

[6]  N. Hafezi-Nejad,et al.  Characterizing a Cohort of α-Thalassemia Couples Collected During Screening for Hemoglobinopathies: 14 Years of an Iranian Experience , 2014, Hemoglobin.

[7]  A. Srivastava,et al.  A stepwise α‐thalassemia screening strategy in high‐prevalence areas , 2013, European journal of haematology.

[8]  Z. Rahimi.  Genetic Epidemiology, Hematological and Clinical Features of Hemoglobinopathies in Iran , 2013, BioMed research international.

[9]  H. Kaya,et al.  Spectrum of α-thalassemia mutations including first observation of - -(FIL) deletion in Hatay Province, Turkey. , 2013, Blood cells, molecules & diseases.

[10]  J. Borgio,et al.  Spectrum of α-Thalassemia Mutations in Transfusion-Dependent β-Thalassemia Patients from the Eastern Province of Saudi Arabia , 2013, Hemoglobin.

[11]  N. Al-Allawi,et al.  Epidemiological profile of common haemoglobinopathies in Arab countries , 2012, Journal of Community Genetics.

[12]  E. Baysal.  Molecular Basis of β-Thalassemia in the United Arab Emirates , 2011, Hemoglobin.

[13]  E. Baysal.  α-Thalassemia Syndromes in the United Arab Emirates , 2011, Hemoglobin.

[14]  N. Fawaz,et al.  Severity ranking of non‐deletional alpha thalassemic alleles: insights from an Omani family study , 2011, European journal of haematology.

[15]  E. Vichinsky,et al.  Heterogeneity of hemoglobin H disease in childhood. , 2011, The New England journal of medicine.

[16]  H. Najmabadi,et al.  Genotype-Phenotype Correlation In Iranian Patients With Hb H Disease , 2011, Hemoglobin.

[17]  Najmabadi Hossein,et al.  A REPORT OF 8 CASES WITH HEMOGLOBIN H DISEASE IN AN IRANIAN FAMILY , 2010, Pediatric hematology and oncology.

[18]  D. Higgs,et al.  α-thalassaemia , 2010, Orphanet Journal of Rare Diseases.

[19]  T. Berbar,et al.  Forecasting Hemoglobinopathy Burden Through Neonatal Screening in Omani Neonates , 2010, Hemoglobin.

[20]  Ş. Yıldız,et al.  Molecular Characterization of α-Thalassemia in Adana, Turkey: A Single Center Study , 2010, Acta Haematologica.

[21]  A. Hellani,et al.  Molecular spectrum of alpha-thalassemia mutations in microcytic hypochromic anemia patients from Saudi Arabia. , 2009, Genetic testing and molecular biomarkers.

[22]  N. Hafezi-Nejad,et al.  α-Thalassemia Mutations in Gilan Province, North Iran , 2009, Hemoglobin.

[23]  H. Najmabadi,et al.  Molecular Characterization of α-Thalassemia in the Dohuk Region of Iraq , 2009, Hemoglobin.

[24]  H. Najmabadi,et al.  α-Thalassemia Mutation Analyses in Mazandaran Province, North Iran , 2009, Hemoglobin.

[25]  H. Siala,et al.  α-Thalassaemia in Tunisia: some epidemiological and molecular data , 2008, Journal of Genetics.

[26]  J. Elion,et al.  Molecular Basis of α-Thalassemia in Algeria , 2008, Hemoglobin.

[27]  N. Hafezi-Nejad,et al.  α-Thalassemia Mutations in Khuzestan Province, Southwest Iran , 2008, Hemoglobin.

[28]  M. Izadyar,et al.  Molecular Basis of Thalassemia Intermedia in Iran , 2008, Hemoglobin.

[29]  H. Najmabadi,et al.  Elucidating the spectrum of α-thalassemia mutations in Iran , 2007 .

[30]  Mehmet Akif Çürük.  Hb H (β4) Disease in Çukurova, Southern Turkey , 2007 .

[31]  M. A. Çürük.  Hb H ( 4 ) Disease in ukurova, Southern Turkey* , 2007 .

[32]  M. Hughson,et al.  Molecular Characterization of β-Thalassemia in the Dohuk Region of Iraq , 2006, Hemoglobin.

[33]  A. Adekile,et al.  Alpha-2-Globin Gene Polyadenylation (AATAAA→AATAAG) Mutation in Hemoglobin H Disease among Kuwaitis , 2005, Medical Principles and Practice.

[34]  S. Chong,et al.  Hemoglobin H disease classification by isoelectric focusing: molecular verification of 110 cases from Thailand. , 2005, Clinical chemistry.

[35]  M. Karimi,et al.  Molecular Basis of Hb H Disease in Southwest Iran , 2005, Hemoglobin.

[36]  J. Ben Chibani,et al.  Clinical and molecular aspects of haemoglobinopathies in Tunisia. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[37]  V. Chan,et al.  Hemoglobin H disease: not necessarily a benign disorder. , 2003, Blood.

[38]  S. Abbès,et al.  Hb H Disease Among Tunisians: Molecular Characterization of α‐Thalassemia Determinants and Hematological Findings , 2003, Hemoglobin.

[39]  D. Higgs,et al.  Hb H hydrops fetalis syndrome associated with the interaction of two common determinants of α thalassaemia (‐‐MED/αTSaudiα) , 2002, British journal of haematology.

[40]  D. J. Weatherall,et al.  Phenotype—genotype relationships in monogenic disease: lessons from the thalassaemias , 2001, Nature Reviews Genetics.

[41]  E. Baysal.  HEMOGLOBINOPATHIES IN THE UNITED ARAB EMIRATES , 2001, Hemoglobin.

[42]  S. Al-Arrayed,et al.  Molecular Basis of α-Thalassemia in Bahrain , 2001 .

[43]  D J Weatherall,et al.  Inherited haemoglobin disorders: an increasing global health problem. , 2001, Bulletin of the World Health Organization.

[44]  I. Papassotiriou,et al.  Phenotypic and molecular diversity of haemoglobin H disease: a Greek experience , 2000, British journal of haematology.

[45]  V. Chan,et al.  Genetic and clinical features of hemoglobin H disease in Chinese patients. , 2000, The New England journal of medicine.

[46]  J. Clegg,et al.  Rapid detection of α‐thalassaemia deletions and α‐globin gene triplication by multiplex polymerase chain reactions , 2000, British journal of haematology.

[47]  B. Al-Awamy.  Thalassemia syndromes in Saudi Arabia. Meta-analysis of local studies. , 2000, Saudi medical journal.

[48]  E. Baysal,et al.  α-Thalassemia in the United Arab Emirates , 1998, Acta Haematologica.

[49]  D. Chui,et al.  Hydrops Fetalis Caused by α-Thalassemia: An Emerging Health Care Problem , 1998 .

[50]  Y. Lau,et al.  Prevalence and genotypes of α- and β-thalassemia carriers in Hong Kong : Implications for population screening , 1997 .

[51]  A. Gürgey,et al.  The molecular basis of Hb H disease in Turkey. , 1997, Hemoglobin.

[52]  M. Angastiniotis,et al.  α‐Thalassaemia in the population of Cyprus , 1995 .

[53]  T. Huisman,et al.  Molecular Characterization of α-Thalassemia Determinants, β-Thalassemia Alleles, and βs Haplotypes among Kuwaiti Arabs , 1994 .

[54]  D. Higgs,et al.  Frequency and clinical significance of erythrocyte genetic abnormalities in Omanis. , 1993, Journal of medical genetics.

[55]  Y. Fei,et al.  Hb H disease in a Turkish family resulting from the interaction of a deletional α‐thalassaemia‐1 and a newly discovered poly A mutation , 1992, British journal of haematology.

[56]  Y. Fei,et al.  Hb H disease caused by a homozygosity for the AATAAA-->AATAAG mutation in the polyadenylation site of the alpha 2-globin gene: hematological observations. , 1992, Acta haematologica.

[57]  J. Clegg,et al.  The polyadenylation site mutation in the alpha-globin gene cluster. , 1988, Blood.

[58]  S. Goodbourn,et al.  The molecular basis of alpha‐thalassaemia in Thailand. , 1984, The EMBO journal.

[59]  S. Goodbourn,et al.  α-Thalassaemia caused by a polyadenylation signal mutation , 1983, Nature.

[60]  M. Pembrey,et al.  A new genetic basis for hemoglobin-H disease. , 1980, The New England journal of medicine.

[61]  G. Stamatoyannopoulos,et al.  Alpha-thalassaemia in Cyprus. , 1979, Journal of medical genetics.

[62]  C. Bate,et al.  Thalassaemia in Cyprus , 1975, Proceedings of the Royal Society of Medicine.